Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Adaptive Biotechnologies Corp (ADPT) vs ARK Fintech Innovation ETF (ARKF) Price & Performance

Adaptive Biotechnologies CorpTrade
ARK Fintech Innovation ETFTrade

Price performance (Past 24H)

Key statistics

Adaptive Biotechnologies Corp vs ARK Fintech Innovation ETF — how do they compare? Adaptive Biotechnologies Corp trades at $25.5 (market cap $4.04B), while ARK Fintech Innovation ETF trades at $42.86. The key difference: Adaptive Biotechnologies Corp is trading nearer its 52-week high, ARK Fintech Innovation ETF nearer its low. Which is the better fit depends on your goals.

ADPTARKF
Market Cap
$4.04B
Sector
HealthSector/Thematic
52-Week High
$25.45$58.82
52-Week Low
$12.30$36.14
Enterprise Value
$4.10B

Returns comparison

Trailing returns across standard periods

About Adaptive Biotechnologies Corp

Adaptive Biotechnologies Corp is a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.

Read more on ADPT

About ARK Fintech Innovation ETF

ARKF is an actively managed ETF that invests in companies leading the way in fintech innovation. Key themes include mobile payments, digital wallets, blockchain technology, and frictionless funding platforms.

Read more on ARKF